Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation

Background: Many patients with diabetes use mixtures of fast-acting (regular human) insulin and intermediate-acting (neutral protamine Hagedorn [NPH]) insulin to control their blood glucose levels. Premixed insulin is available in a 70%/30% mixture and a 50%/50% mixture of NPH/regular human insulin....

Ausführliche Beschreibung